Follow the 에스엘에스바이오 share price and the full directors' dealings record of the company, a publicly traded company based in South Korea. Shares are listed on the KR market, under the authority of DART (FSS). Operating in the Health Care sector, 에스엘에스바이오 has published 22 reports. Market capitalisation: €29.6bn. The latest transaction was filed on 10 March 2026 (Other). Among the most active insiders: 문해란. All data is openly available.
22
Insider Decl.
n/a
Thresholds
n/a
11 ops.
Buy Volume
n/a
5 ops.
Sell Volume
22Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 28,712 of 29,063 companies
8.0
score / 100
Value
13
Quality
3
FCF yld-13%
Earn yld-17%
EV/EBITDA·
ROE-59%
Gross mgn-49%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.